COVENTRY, 15-Jun-2018 — /EuropaWire/ — The University of Warwick is set to receive £1.2 million in funding to support its pioneering research in improving the resilience, sustainability and productivity of UK crops, Environment Secretary Michael Gove has announced today.
A £5.3 million funding package shared between four of the UK’s leading agricultural research centres is set to help develop new technologies and environmentally innovative food production for farmers and growers across the country.
Research teams at the University of Warwick will use their share of the funding to develop new scientific insights to boost the productivity for leafy vegetables as part of Defra’s Crop Genetic Improvement Networks (GINs).
Environment Secretary Michael Gove said: “Developing new technology is crucial to making sure our farmers continue to innovate, growing world-class produce in an environmentally friendly way.
“Through this new funding, I hope to see new growing practices and crop protections develop so we can truly unlock the potential of our food and farming industries.”
Since opening in 2009, the University of Warwick’s vegetable research programme has:
Dr Guy Barker, who leads on the Vegetable GIN at the University of Warwick, said: “The Vegetable GIN supports the horticultural sector to address the challenges associated with sustainable production.
“We welcome the opportunities presented by Defra’s five-year commitment, allowing us to utilise the unique diversity available from the UK Vegetable Genebank to produce more resilient crops varieties for future generations.”
SOURCE: University of Warwick
Contacts
Press Office
+44 (0)24 7652 4668
Peter Dunn
Director of Press and Policy p.j.dunn@warwick.ac.uk
+44 (0)24 7652 3708
Tom Frew
Senior Press and Media Relations Manager a.t.frew@warwick.ac.uk
+44 (0)24 7657 5910
(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its…
(IN BRIEF) Last Friday, NMB Bank Plc celebrated the listing of its dual-currency sustainability bond,…
(IN BRIEF) CapMan Nordic Infrastructure II fund has reached its final closing at over €375…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated…
(IN BRIEF) AstraZeneca's Truqap, in combination with Faslodex, has received a positive recommendation from the…
(IN BRIEF) Ørsted, a global leader in renewable energy, is divesting its French onshore operations…